Worth a Look
Qualify for a free subscription to HealthLeaders magazine.
“Bandages” and “shrimp” are two words you don’t expect to hear in the same sentence. But for one Portland, OR-based company, they go together just fine.
HemCon Medical Technologies worked with the U.S. Army to develop a bandage made from chitosan, a naturally occurring, biocompatible substance derived from shrimp shells. The shells are processed, treated, formed into bandages and sterilized. The idea is that the chitosan attracts blood cells and seals a wound to allow the body to form a clot that stops hemorrhaging. And what if the patient has a shellfish allergy? HemCon says no known allergic reactions have occurred since the product launched in 2003.
Originally developed for use on the battlefield, the dressings are now used in acute-care settings through a distributorship agreement reached last fall with Dublin, OH-based Cardinal Health. Go to either www.hemcon.com or www.cardinalhealth.com to read more.
- Surgical Checklists Unused in 10% of Hospitals, CMS Data Shows
- Roundtable: To Arrest HAIs, Culture Trumps Campaigns
- Doctors Feel Pressure to Accept Risk-based Reimbursement
- Wanted: Nurse PhDs
- Slideshow: Healthcare Leaders Name IT Spending Priorities
- 4 Tectonic Shifts Shaking Up Healthcare
- A Fresh Look at End-of-Life Care
- New Orleans East Hospital opens quietly, still seeking accreditation
- 3 Insider Tips on Cutting Costs without Strangling Growth
- CVS Ramps Up Retail Clinics with Provider Affiliations